+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Neuropathy Pain Treatment Market by Pain Type (Coccydynia, Entrapment Neuropathy, Foot Pain), Indication (Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Spinal Stenosis), Treatment, Distribution Channel, End-User - Forecast 2024-2030- Product Image
Global Neuropathy Pain Treatment Market by Pain Type (Coccydynia, Entrapment Neuropathy, Foot Pain), Indication (Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Spinal Stenosis), Treatment, Distribution Channel, End-User - Forecast 2024-2030- Product Image
Sale

Global Neuropathy Pain Treatment Market by Pain Type (Coccydynia, Entrapment Neuropathy, Foot Pain), Indication (Chemotherapy-Induced Peripheral Neuropathy, Diabetic Neuropathy, Spinal Stenosis), Treatment, Distribution Channel, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666258
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neuropathy Pain Treatment Market size was estimated at USD 7.74 billion in 2023, USD 8.59 billion in 2024, and is expected to grow at a CAGR of 11.53% to reach USD 16.61 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Neuropathy Pain Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Neuropathy Pain Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Neuropathy Pain Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Assertio Holdings, Inc., Astellas Pharma Inc., AstraZeneca PLC, Aurobindo Pharma Limited, Baxter International Inc., Biogen Inc., Bristol Myers Squibb Company, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, GlaxoSmithKline PLC, Johnson and Johnson Services, Inc., Novartis AG, Pfizer Inc., and Sun Pharmaceutical Industries Limited.

Market Segmentation & Coverage

This research report categorizes the Neuropathy Pain Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Pain Type
    • Coccydynia
    • Entrapment Neuropathy
    • Foot Pain
    • Peripheral Neuropathy
    • Phantom Limb Neuropathy
    • Post Herpetic Neuralgia (PHN)
    • Post Traumatic Neuropathy
    • Trigeminal Neuralgia
  • Indication
    • Chemotherapy-Induced Peripheral Neuropathy
    • Diabetic Neuropathy
    • Spinal Stenosis
  • Treatment
    • Drugs
      • Antidepressant Drugs Type
        • Serotonin Noradrenaline
        • Tricyclic Antidepressants
      • Medication Type
      • Multimodal Therapy
      • NSAIDs Type
        • Ibuprofen
        • Naproxen
    • Therapy
  • Distribution Channel
    • Online Pharmacies
    • Retail Pharmacies & Drug Stores
  • End-User
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Neuropathy Pain Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Neuropathy Pain Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Neuropathy Pain Treatment Market?
  4. What is the market share of the leading vendors in the Neuropathy Pain Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Neuropathy Pain Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Neuropathy Pain Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in neuropathic pain among population
5.1.1.2. Increasing global healthcare expenditure
5.1.1.3. Growing number of neuropathic pain relievers and over-the-counter products
5.1.2. Restraints
5.1.2.1. Limited awareness of available treatment options
5.1.3. Opportunities
5.1.3.1. Introduction of novel pain treatment alternatives
5.1.3.2. Programs and initiatives focusing on palliative care
5.1.4. Challenges
5.1.4.1. Complexity in identifying the treatment suitable for neuropathic pains in a patient
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Neuropathy Pain Treatment Market, by Pain Type
6.1. Introduction
6.2. Coccydynia
6.3. Entrapment Neuropathy
6.4. Foot Pain
6.5. Peripheral Neuropathy
6.6. Phantom Limb Neuropathy
6.7. Post Herpetic Neuralgia (PHN)
6.8. Post Traumatic Neuropathy
6.9. Trigeminal Neuralgia
7. Neuropathy Pain Treatment Market, by Indication
7.1. Introduction
7.2. Chemotherapy-Induced Peripheral Neuropathy
7.3. Diabetic Neuropathy
7.4. Spinal Stenosis
8. Neuropathy Pain Treatment Market, by Treatment
8.1. Introduction
8.2. Drugs
8.3.1. Antidepressant Drugs Type
8.3.2.1. Serotonin Noradrenaline
8.3.2.2. Tricyclic Antidepressants
8.3.2. Medication Type
8.3.3. Multimodal Therapy
8.3.4. NSAIDs Type
8.3.5.1. Ibuprofen
8.3.5.2. Naproxen
8.3. Therapy
9. Neuropathy Pain Treatment Market, by Distribution Channel
9.1. Introduction
9.2. Online Pharmacies
9.3. Retail Pharmacies & Drug Stores
10. Neuropathy Pain Treatment Market, by End-User
10.1. Introduction
10.2. Clinics
10.3. Hospitals
11. Americas Neuropathy Pain Treatment Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Neuropathy Pain Treatment Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Neuropathy Pain Treatment Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
15. Competitive Portfolio
15.1. Key Company Profiles
15.1.1. Abbott Laboratories
15.1.2. Assertio Holdings, Inc.
15.1.3. Astellas Pharma Inc.
15.1.4. AstraZeneca PLC
15.1.5. Aurobindo Pharma Limited
15.1.6. Baxter International Inc.
15.1.7. Biogen Inc.
15.1.8. Bristol Myers Squibb Company
15.1.9. Dr. Reddy’s Laboratories Ltd.
15.1.10. Eli Lilly and Company
15.1.11. GlaxoSmithKline PLC
15.1.12. Johnson and Johnson Services, Inc.
15.1.13. Novartis AG
15.1.14. Pfizer Inc.
15.1.15. Sun Pharmaceutical Industries Limited
15.2. Key Product Portfolio
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. NEUROPATHY PAIN TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. NEUROPATHY PAIN TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. NEUROPATHY PAIN TREATMENT MARKET DYNAMICS
FIGURE 7. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2023 VS 2030 (%)
FIGURE 8. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 12. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 16. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 20. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 25. NEUROPATHY PAIN TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 26. NEUROPATHY PAIN TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. NEUROPATHY PAIN TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. NEUROPATHY PAIN TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 6. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COCCYDYNIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ENTRAPMENT NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY FOOT PAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PERIPHERAL NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PHANTOM LIMB NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST HERPETIC NEURALGIA (PHN), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY POST TRAUMATIC NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRIGEMINAL NEURALGIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 15. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DIABETIC NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SPINAL STENOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 19. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 21. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 23. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY SEROTONIN NORADRENALINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TRICYCLIC ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MEDICATION TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY MULTIMODAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 29. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY RETAIL PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. NEUROPATHY PAIN TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 64. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 67. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 68. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. CANADA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 72. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. MEXICO NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 89. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 97. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 98. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 106. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 108. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 109. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 110. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 111. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. CHINA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 114. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 115. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 116. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 117. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 118. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 119. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. INDIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 122. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 124. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 130. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 132. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 133. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 134. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 135. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. JAPAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 138. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 139. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 146. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 148. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 154. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 155. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 156. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 162. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 164. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 170. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 171. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 172. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 178. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 179. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 180. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 181. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 182. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 183. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. THAILAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 186. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 187. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 188. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 202. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 203. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 204. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 205. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. DENMARK NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 210. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 211. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 212. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 213. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 214. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 216. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. EGYPT NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 218. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 220. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 221. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 222. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. FINLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 227. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 228. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 229. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 230. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 231. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 232. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. FRANCE NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 235. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 236. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 237. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 238. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 239. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 240. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. GERMANY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 251. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 252. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 253. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 254. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 255. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 256. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. ITALY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 259. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 260. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 261. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 275. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 276. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 277. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 278. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 279. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 280. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. NORWAY NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 283. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 284. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 285. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 286. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 287. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 288. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. POLAND NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 290. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 291. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 292. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 293. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 294. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 295. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 296. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 297. QATAR NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 299. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 300. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 301. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 308. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 314. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 316. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA NEUROPATHY PAIN TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 322. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY PAIN TYPE, 2018-2030 (USD MILLION)
TABLE 323. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 324. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 325. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
TABLE 326. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY ANTIDEPRESSANT DRUGS TYPE, 2018-2030 (USD MILLION)
TABLE 327. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY NSAIDS TYPE, 2018-2030 (USD MILLION)
TABLE 328. SPAIN NEUROPATHY PAIN TREATMENT MARKET SIZE, BY DISTRIB

Companies Mentioned

  • Abbott Laboratories
  • Assertio Holdings, Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Aurobindo Pharma Limited
  • Baxter International Inc.
  • Biogen Inc.
  • Bristol Myers Squibb Company
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Johnson and Johnson Services, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 8.59 Billion
Forecasted Market Value ( USD ) by 2030 $ 16.61 Billion
Compound Annual Growth Rate11.5%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Global Diabetic Neuropathy Market by Treatment Type (Drugs, Physiotherapy), Disorder Type (Autonomic Neuropathy, Focal Neuropathy, Peripheral Neuropathy), Distribution channel - Forecast 2023-2030 - Product Image

Global Diabetic Neuropathy Market by Treatment Type (Drugs, Physiotherapy), Disorder Type (Autonomic Neuropathy, Focal Neuropathy, Peripheral Neuropathy), Distribution channel - Forecast 2023-2030

  • Report
  • 183 Pages
  • Global
From
Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy), Drug Class (NSAIDs, Capsaicin, Opioid), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Image

Global Diabetic Neuropathy Treatment Market Size, Share & Trends Analysis Report by Disorder Type (Peripheral Neuropathy, Autonomic Neuropathy), Drug Class (NSAIDs, Capsaicin, Opioid), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • 150 Pages
  • Global
From
Chemotherapy-induced Peripheral Neuropathy - Market Insight, Epidemiology and Market Forecast - 2032 - Product Image

Chemotherapy-induced Peripheral Neuropathy - Market Insight, Epidemiology and Market Forecast - 2032

  • Report
  • 159 Pages
  • Global
From
Global Neuropathy Pain Treatment Market 2024-2028 - Product Image

Global Neuropathy Pain Treatment Market 2024-2028

  • Report
  • 171 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024 - Product Image

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.